HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyung Gyun Kim Selected Research

rubimaillin

5/2013Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells.
5/2013Mollugin inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hyung Gyun Kim Research Topics

Disease

21Neoplasms (Cancer)
01/2022 - 02/2010
10Breast Neoplasms (Breast Cancer)
01/2022 - 08/2008
6Inflammation (Inflammations)
01/2017 - 10/2010
5Atopic Dermatitis (Atopic Eczema)
07/2014 - 05/2012
4Hypoxia (Hypoxemia)
01/2022 - 05/2008
4Carcinogenesis
12/2021 - 04/2008
4Neoplasm Metastasis (Metastasis)
03/2019 - 11/2006
4Fibrosarcoma
03/2019 - 04/2011
4Hepatocellular Carcinoma (Hepatoma)
03/2012 - 12/2009
3Fibrosis (Cirrhosis)
01/2017 - 06/2013
3Atherosclerosis
02/2016 - 01/2006
3Dermatitis
07/2014 - 03/2013
3Obesity
01/2013 - 02/2010
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2017 - 06/2013
2Carcinoma (Carcinomatosis)
01/2014 - 09/2013
1Alcoholic Fatty Liver
02/2017
1Asthma (Bronchial Asthma)
01/2017
1Vascular Diseases (Vascular Disease)
02/2016
1Colonic Neoplasms (Colon Cancer)
09/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2013
1Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2013

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
08/2017 - 08/2008
7AntioxidantsIBA
06/2013 - 08/2008
6SaponinsIBA
02/2017 - 01/2006
5Messenger RNA (mRNA)IBA
08/2017 - 03/2013
5Cytochrome P-450 CYP1A1 (CYP1A1)IBA
09/2015 - 04/2008
5ChangkilIBA
02/2015 - 01/2006
4Pharmaceutical PreparationsIBA
09/2017 - 05/2011
4Dinitrochlorobenzene (DNCB)IBA
07/2014 - 05/2012
4Immunoglobulin E (IgE)IBA
07/2014 - 08/2012
4CytokinesIBA
01/2014 - 01/2006
3kahweolIBA
03/2019 - 12/2006
3p38 Mitogen-Activated Protein KinasesIBA
03/2019 - 04/2011
3Dimethylnitrosamine (Nitrosodimethylamine)IBA
01/2017 - 01/2011
3Capsaicin (Zostrix)FDA Link
01/2017 - 04/2011
3ElementsIBA
09/2015 - 07/2010
3Metformin (Glucophage)FDA LinkGeneric
10/2014 - 09/2013
3Interleukin-4 (Interleukin 4)IBA
07/2014 - 03/2013
3Interleukin-13IBA
07/2014 - 03/2013
3Interleukin-5 (Interleukin 5)IBA
07/2014 - 03/2013
3Biological ProductsIBA
07/2014 - 05/2011
3EnzymesIBA
06/2013 - 04/2008
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
05/2011 - 01/2011
3Transcription Factor AP-1 (Transcription Factor AP 1)IBA
04/2011 - 02/2010
3Metallothionein 3IBA
12/2009 - 05/2008
2Estrogens (Estrogen)FDA Link
01/2022 - 08/2017
2Estrogen ReceptorsIBA
01/2022 - 08/2008
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2022 - 10/2014
2LeptinIBA
08/2017 - 05/2014
2Aromatase (CYP19)IBA
08/2017 - 10/2010
2PPAR gammaIBA
01/2017 - 04/2008
2OvalbuminIBA
01/2017 - 02/2015
2LigandsIBA
10/2014 - 05/2014
2Heme Oxygenase-1IBA
07/2014 - 09/2013
2piperineIBA
12/2013 - 05/2011
2artenimol (dihydroartemisinin)IBA
06/2013 - 06/2010
2artemisinin (artemisinine)IBA
06/2013 - 06/2010
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
05/2013 - 03/2011
2rubimaillinIBA
05/2013 - 05/2013
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2013 - 07/2010
2Sterol Regulatory Element Binding Protein 1IBA
05/2013 - 01/2013
2LipidsIBA
01/2013 - 12/2011
2Anthocyanins (Anthocyanin)IBA
12/2011 - 01/2011
2puerarinIBA
11/2011 - 07/2010
2NF-kappa B (NF-kB)IBA
07/2010 - 06/2010
1LuciferasesIBA
01/2022
1Small Interfering RNA (siRNA)IBA
01/2022
1ChromatinIBA
01/2022
14- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA
12/2021
1SmokeIBA
12/2021
1phorbolIBA
03/2019
1Aromatase InhibitorsIBA
08/2017
1Estradiol (Delestrogen)FDA LinkGeneric
08/2017
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2017
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
08/2017
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2017
1theanineIBA
01/2017
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
02/2016
1Betulinic AcidIBA
02/2016
1TriterpenesIBA
02/2016
1caffeic acid phenethyl esterIBA
09/2015
1AllergensIBA
02/2015
1platyconic acidIBA
02/2015
1XenobioticsIBA
10/2014
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
10/2014
1Polychlorinated Dibenzodioxins (TCDD)IBA
10/2014
1MicroRNAs (MicroRNA)IBA
09/2014
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
09/2014
1Death Domain ReceptorsIBA
09/2014
1Caspase 8 (Caspase-8)IBA
09/2014
1Sirtuin 1IBA
09/2014
1ilimaquinoneIBA
09/2014
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2014
1Paclitaxel (Taxol)FDA LinkGeneric
12/2013
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
09/2013
1Alanine Transaminase (SGPT)IBA
06/2013
1CollagenIBA
06/2013

Therapy/Procedure

2Therapeutics
01/2022 - 09/2013
2Drug Therapy (Chemotherapy)
09/2013 - 07/2010
1Radiotherapy
09/2013